JPS5822032B2 - β-oxysulfoxide derivative and method for producing the same - Google Patents
β-oxysulfoxide derivative and method for producing the sameInfo
- Publication number
- JPS5822032B2 JPS5822032B2 JP6062776A JP6062776A JPS5822032B2 JP S5822032 B2 JPS5822032 B2 JP S5822032B2 JP 6062776 A JP6062776 A JP 6062776A JP 6062776 A JP6062776 A JP 6062776A JP S5822032 B2 JPS5822032 B2 JP S5822032B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- chloroform
- multiplet
- double line
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000003435 aroyl group Chemical group 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 230000002152 alkylating effect Effects 0.000 claims 1
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 38
- 239000000203 mixture Substances 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- -1 butyroyl Chemical group 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000010446 mirabilite Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OTKFCIVOVKCFHR-UHFFFAOYSA-N (Methylsulfinyl)(methylthio)methane Chemical compound CSCS(C)=O OTKFCIVOVKCFHR-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241001643623 Enteles Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Substances CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は一般式
(式中、R”及びR2はアルキル基であり、R3はアル
キル基、アシル基またはアロイル基である。DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula (wherein R'' and R2 are alkyl groups, and R3 is an alkyl group, an acyl group, or an aroyl group).
)で示されるβ−オキシヌルホキシト誘導体及びその製
造法に関するものである。) and a method for producing the same.
R1及びR2のアルキル基としては例えばメチル、エチ
ル、プロピル、ブチル基のようなアルキル基などが挙げ
られる。Examples of the alkyl groups for R1 and R2 include alkyl groups such as methyl, ethyl, propyl, and butyl groups.
またR3のアルキル基としてはメチル、エチル、プロピ
ル基など、アシル基としてはアセチル、プロピオニル、
ブチロイル、フェニルアセチル基などがある。In addition, the alkyl group of R3 includes methyl, ethyl, propyl group, etc., and the acyl group includes acetyl, propionyl,
Examples include butyroyl and phenylacetyl groups.
アロイル基としてはベンゾイル、2,4−ジニトロベン
ゾイル基などがある。Examples of the aroyl group include benzoyl and 2,4-dinitrobenzoyl groups.
具体的な化合物としては1−メトキシ−1−(3−クロ
ロ−4−アリルオキシフェニル)−2−メチルヌルフィ
ニル−2−メチルチオエタン、1−アセトキシ−1−(
3−クロロ−4−アリルオキシフェニル)−2−メチル
スルフィニル−2−メチルチオエタン、■−ベンゾイル
オキシー1−(3−クロロ−4−アリルオキシフェニル
ニー2−メチルヌルフィニル−2−メチルチオエタンな
どがある。Specific compounds include 1-methoxy-1-(3-chloro-4-allyloxyphenyl)-2-methylnurfinyl-2-methylthioethane, 1-acetoxy-1-(
3-chloro-4-allyloxyphenyl)-2-methylsulfinyl-2-methylthioethane, ■-benzoyloxy-1-(3-chloro-4-allyloxyphenyl-2-methylnurfinyl-2-methylthioethane, etc. There is.
本発明で得られる化合物類はすべて文献未知物質であり
ラットを用いてのカラゲニン浮腫法で消炎作用が認めら
れ医薬品として有用なものである。All of the compounds obtained in the present invention are unknown substances in the literature, and their anti-inflammatory effects have been observed in the carrageenan edema method using rats, making them useful as pharmaceuticals.
また本発明で得られる化合物はこれより適当な化学的手
段(下記参考側参照)を施すことにより消炎剤として賞
月されている3−り四ロー4−アリルオキシフェニル酢
酸に収率よく誘導できることから重要な医薬品の中間体
である。Furthermore, the compound obtained in the present invention can be derived in good yield into 3-4-4-allyloxyphenylacetic acid, which is prized as an anti-inflammatory agent, by applying appropriate chemical means (see reference side below). It is an important pharmaceutical intermediate.
本発明の製造方法は一般式 (式中、R”及びR2はアルキル基である。The manufacturing method of the present invention is based on the general formula (In the formula, R'' and R2 are alkyl groups.
)で示されるα−ヒドロキシアルデヒドメルカプタール
S−オキシド類を原料とするものであるが、この化合物
は本発明渚等が開発した方法により容易に製造できるも
のである。), and this compound can be easily produced by the method developed by Nagisa et al. of the present invention.
即ち、3−クロロ−4−アリルオキシ安息香酸エステル
と一般式RISCH2SOR2・・・(III)(式中
、R1及びR2はアルキル基である。That is, 3-chloro-4-allyloxybenzoic acid ester and the general formula RISCH2SOR2 (III) (wherein R1 and R2 are alkyl groups).
)で示されるα位にヌルフィト結合を有するヌルホキシ
トとを塩基の存在下で反応させて得られる一般式
(式中、R1及びR2はアルキル基である。) with a nulphoxyto having a nulphite bond at the α-position in the presence of a base (wherein R1 and R2 are alkyl groups).
)で示される化合物を還元することにより所望化合物(
II)を製造できる(下記参考側参照)01 本発明の
方法は前記一般式(II)で表わされるα−ヒドロキシ
アルデヒドメルカプタールS−オキシド類をアルキル化
、アシル化、アシル化またはアロイル化することを特徴
とするものである。) to obtain the desired compound (
II) can be produced (see reference side below) 01 The method of the present invention alkylates, acylates, acylates or aroylates α-hydroxyaldehyde mercaptal S-oxides represented by the general formula (II). It is characterized by this.
アルキル化はそれぞれ対応するアルキル化剤と反応させ
ることにより達成できる。Alkylation can be achieved by reacting with the respective corresponding alkylating agent.
ここに用いるアルキル化剤ξしてはヨウ化メチルや臭化
ベンジルのようなハロゲン化アルキル、ジメチル硫酸の
ようなジアルキル硫酸あるいはフルオロヌルホン酸メチ
ルやトリフルオロメタンヌルホン酸メチルのようなヌル
ホン酸アルキルエヌテル等を挙ケることができる。The alkylating agent ξ used here is an alkyl halide such as methyl iodide or benzyl bromide, a dialkyl sulfate such as dimethyl sulfate, or an alkyl nulphonate such as methyl fluoronurulfonate or methyl trifluoromethane sulfonate. Entel, etc. can be mentioned.
この反応では塩基の存在が好ましく、使用できる塩基と
しては水素化ナトリウム、n−7”チルリチウム、リチ
ウムジエチルアミドの如き強塩基を挙げることができる
。In this reaction, the presence of a base is preferred, and examples of the base that can be used include strong bases such as sodium hydride, n-7'' chilllithium, and lithium diethylamide.
アシル化およびアロイル化はそれぞれ対応する酸ハライ
ドあるいは酸無水物を塩基の存在下あるいは無しで反応
させることにより達成でき、好収率で所望化合物(I)
を得ることができる。Acylation and aroylation can be achieved by reacting the corresponding acid halide or acid anhydride in the presence or absence of a base, and the desired compound (I) can be obtained in good yield.
can be obtained.
(式中、R1およびR2はアルキル基を表わし、R3は
アルキル基、アシル基またはアロイル基を表わす)。(In the formula, R1 and R2 represent an alkyl group, and R3 represents an alkyl group, an acyl group, or an aroyl group).
本発明の実施にあたっては溶媒としてベンゼン、トルエ
ン、ピリジン、ジエチルエーテルテトラヒドロフラン、
クロロホルムの如き反応に関与しない非プロトン性有機
溶媒を用いることが出来る。In carrying out the present invention, benzene, toluene, pyridine, diethyl ether tetrahydrofuran,
Aprotic organic solvents that do not participate in the reaction, such as chloroform, can be used.
反応は特別な加熱又は冷却手段を用いることなく室温下
で円滑に進行するが所望であれば加熱しても良い。The reaction proceeds smoothly at room temperature without using any special heating or cooling means, but heating may be performed if desired.
また大量に行なう場合には発熱を伴う場合があるので冷
却手段を用いて温度制御しても良い。Furthermore, when a large amount is used, heat may be generated, so a cooling means may be used to control the temperature.
本発明で得られた化合物は文献未知であり、赤外線吸収
スペクトル、核磁気共鳴スペクトル及び元素分析などに
よりその構造を確認した。The compound obtained in the present invention is unknown in literature, and its structure was confirmed by infrared absorption spectrum, nuclear magnetic resonance spectrum, elemental analysis, etc.
次に実施例及び参考例にて本反応を具体的に説明するが
これに限定されるものではない。Next, this reaction will be specifically explained in Examples and Reference Examples, but is not limited thereto.
実施例 1
1−ヒドロキシ−1−(3−クロロ−4−アリルオキシ
フェニル)−2−メチルスルフィニル−2−メチルチオ
エタン1001n?、ピリジン2.5−1無水酢酸2.
57!の混合物を室温で15時間攪拌したのち、過剰の
ピリジン及び無水酢酸を減圧留去する。Example 1 1-Hydroxy-1-(3-chloro-4-allyloxyphenyl)-2-methylsulfinyl-2-methylthioethane 1001n? , pyridine 2.5-1 acetic anhydride 2.
57! After stirring the mixture at room temperature for 15 hours, excess pyridine and acetic anhydride were distilled off under reduced pressure.
残渣はクロロホルム20m1に溶解し、水5−で洗浄し
芒硝乾燥後溶媒留去。The residue was dissolved in 20 ml of chloroform, washed with water, dried with sodium sulfate, and the solvent was distilled off.
更にカラムクロマトグラフィー(シリカゲル、クロロホ
ルム)により分離精製し、■−アセトキシー1−(3−
クロロ−4−アリルオキシフェニル)−2−メチルヌル
フィニル−2−メチルチオエタンを油状物として100
mfI(収率90%)得た。It was further separated and purified by column chromatography (silica gel, chloroform) to obtain ■-acetoxy 1-(3-
100% of chloro-4-allyloxyphenyl)-2-methylnurfinyl-2-methylthioethane as an oil.
mfI (yield 90%) was obtained.
IR(neat ) : 1740CrfL−1NMR
(CDCl2):δ2.08 (3H,−重線)。IR (neat): 1740CrfL-1NMR
(CDCl2): δ2.08 (3H, - double line).
2.20(3H,−重線)、2.69(3H,−重線)
、4.24(IH,二重線、J= 8 Hz ) 。2.20 (3H, - double line), 2.69 (3H, - double line)
, 4.24 (IH, doublet, J=8 Hz).
4.66(2H,二重線、J= 4.5 Hz ) 。4.66 (2H, doublet, J=4.5 Hz).
6.05(IH,二重線、J= 8Hz )、 5.2
5−6.30(3H,多重線) 、 6.7−7.7
(3H1多重線)・
元素分析(C15H1,04S2C1):計算値%):
C・49.64;H,5,27;S、 17.67゜実
験値(至):C,49,58;H,5,31;S、 1
7.77゜実施例 2
■−ヒドロキシー1−(3−クロロ−4−アリルオキシ
フェニル)−2−メチルスルフィニル−2−メチルチオ
エタン1.2yのクロロホルム40彪溶液に10%水酸
化すl−IJウム水溶液30m1を加え、室温で攪拌下
にベンゾイルクロリド2.2gを滴加、滴加終了後さら
に16時間攪拌、クロロホルム層を分取し水洗、炭酸カ
リウムで乾燥後クロロホルムを留去。6.05 (IH, double line, J=8Hz), 5.2
5-6.30 (3H, multiplet), 6.7-7.7
(3H1 multiplet) Elemental analysis (C15H1,04S2C1): Calculated value %):
C・49.64; H, 5,27; S, 17.67° Experimental value (to): C, 49,58; H, 5,31; S, 1
7.77゜Example 2 ■-Hydroxy-1-(3-chloro-4-allyloxyphenyl)-2-methylsulfinyl-2-methylthioethane in a solution of 1.2y in chloroform at 10% hydroxide l-IJ 2.2 g of benzoyl chloride was added dropwise with stirring at room temperature, and after the dropwise addition was completed, the mixture was further stirred for 16 hours. The chloroform layer was separated, washed with water, dried over potassium carbonate, and the chloroform was distilled off.
得られた油状物をカラムクロマトグラフィー(シリカゲ
ル、クロロホルム)で分離精製し1−ヘンジイルオキシ
−1−(3−’70ロー4−アリルオキシフェニル)−
2−メチルスルフィニル−2−メチルチオエタンi、o
、y(収率64%)を無色油状物として得た。The obtained oil was separated and purified by column chromatography (silica gel, chloroform) to give 1-hendiyloxy-1-(3-'70rho-4-allyloxyphenyl)-
2-methylsulfinyl-2-methylthioethane i,o
, y (yield 64%) was obtained as a colorless oil.
IR(neat ) : i 72ocm−’ 、 1
640cIIl−”および1060cm−” 。IR (neat): i72ocm-', 1
640cIIl-” and 1060cm-”.
実施例 3
■−ヒドロキシー1−(3−クロロ−4−アリルオキシ
フェニル)−2−メチルヌルフィニル−2−メチルチオ
エタン6007nfIをジメチルヌルホキシト5rnl
にとかし、ヨウ化メチル1彪を加えたのち、水素化ナト
リウム1.1(50%含有)を添加する。Example 3 ■-Hydroxy-1-(3-chloro-4-allyloxyphenyl)-2-methylnurfinyl-2-methylthioethane 6007nfI was mixed with dimethylnulfoxide 5rnl
After stirring to dissolve and add 1 Biao of methyl iodide, 1.1 (containing 50%) of sodium hydride is added.
更にヨウ化メチルlydを加えて室温で10時間攪拌、
クロロホルム1007727!!を加え、水洗後芒硝乾
燥して減圧濃縮する。Furthermore, methyl iodide lyd was added and stirred at room temperature for 10 hours.
Chloroform 1007727! ! After washing with water, dry the sodium sulfate and concentrate under reduced pressure.
残留物をカラムクロマトグラフィー(シリカゲル、クロ
ロホルム)で分離して無色油状物として1−メトキシ−
1−(3−クロロ−4−アリルオキシフェニル)−2−
メチルヌルフィニル−2−メチルチオエタン470q(
収率75%)を得た。The residue was separated by column chromatography (silica gel, chloroform) to give 1-methoxy-
1-(3-chloro-4-allyloxyphenyl)-2-
Methylnurfinyl-2-methylthioethane 470q (
A yield of 75% was obtained.
IR(neat ) : 1060crfL−” 。IR (neat): 1060crfL-”.
NMR(CDCl2):δ2.08(3H,−重線)。NMR (CDCl2): δ2.08 (3H, - double line).
2.80 (3H,−重線) 、 3.45 (3H,
−重線)3.65 (IHs二重線、J=4.5Hz
)、 4.8.5(2Hに重線、J = 4.5 Hz
) 5.28−6.50(4H1多重線) 、 7.
28−8.1 (’3H,多重線)。2.80 (3H, - double line), 3.45 (3H,
- double line) 3.65 (IHs double line, J = 4.5Hz
), 4.8.5 (double line on 2H, J = 4.5 Hz
) 5.28-6.50 (4H1 multiplet), 7.
28-8.1 ('3H, multiplet).
参考例 1
メチルメチルチオメチルスルホキシド1.09.9をテ
トラヒドロフラン10m1にとかし、水冷下水素化ナト
リウム(50%含有)9007M?を加え30分攪拌す
る。Reference Example 1 Methyl methyl thiomethyl sulfoxide 1.09.9 was dissolved in 10 ml of tetrahydrofuran, and under water cooling, sodium hydride (containing 50%) 9007M? Add and stir for 30 minutes.
室温下、3−クロロ−4−アリルオキシ安息香酸メチル
2.0gを加え、更に19時間攪拌する。At room temperature, 2.0 g of methyl 3-chloro-4-allyloxybenzoate was added, and the mixture was further stirred for 19 hours.
クロロホルム40−1酢酸5−および水2彪を加えたの
ち、芒硝と炭酸カリウムで乾燥する。After adding 40 parts of chloroform, 5 parts of acetic acid, and 2 parts of water, the mixture is dried with Glauber's salt and potassium carbonate.
溶媒を減圧濃縮後カラムクロマトグラフィー(シリカゲ
ル、クロロホルム)により分離し、■−オキソー1−(
3−クロロ−4−アリルオキシフェニル)−2−メチル
スルフィニル−2=メチルチオエクン1.95.9(収
率70%)を淡黄色消状物質として得た。After concentrating the solvent under reduced pressure, it was separated by column chromatography (silica gel, chloroform) to give ■-oxo 1-(
1.95.9 (yield: 70%) of 3-chloro-4-allyloxyphenyl)-2-methylsulfinyl-2=methylthioechune was obtained as a pale yellow eraser.
このものはNMRから2種の立体異性体の3:4混合物
であることが明らかとなった。NMR revealed that this product was a 3:4 mixture of two stereoisomers.
IR(neat ) : 1660cm−’と1050
cm−’ 。IR (neat): 1660cm-' and 1050
cm-'.
NMR(CDCl2):
成分A:δ2.12(3H,−重線)2.87(3H1
−重線)。NMR (CDCl2): Component A: δ2.12 (3H, - heavy line) 2.87 (3H1
- heavy line).
成分B:δ2.22(3H,−重線)2.64(3H1
−重線)。Component B: δ2.22 (3H, - double line) 2.64 (3H1
- heavy line).
成分A、B共通:δ4.65 (2H,二重線、J=4
.5Hz)、5.18 6.30(3Hs多重線)。Common to components A and B: δ4.65 (2H, double line, J=4
.. 5Hz), 5.18 6.30 (3Hs multiplet).
元素分析(C13H1503CIS2):計J[H:C
,48,96;H,474;S、20.11゜実験値(
至): C,48,87;H,4,58;S 、 19
.93゜参考例 2
■−オキソー1−(3−クロロ−4−アリルオキシフェ
ニル)−2−メチルスルフィニル−2−メチルチオエタ
ン1.OIをメタノール50−に溶解し、水冷下、水素
化ホウ素ナトリウム120111fIを加え、室温で3
時間攪拌したのちアセトン1rIllにて過剰の水素化
ホウ素ナトリウムを分解し、減圧濃縮する。Elemental analysis (C13H1503CIS2): Total J[H:C
, 48, 96; H, 474; S, 20.11° experimental value (
To): C, 48, 87; H, 4, 58; S, 19
.. 93° Reference Example 2 ■-Oxo-1-(3-chloro-4-allyloxyphenyl)-2-methylsulfinyl-2-methylthioethane 1. Dissolve OI in 50-methanol, add 120111fI of sodium borohydride under water cooling, and dissolve at room temperature for 30 minutes.
After stirring for an hour, excess sodium borohydride was decomposed with 1 l of acetone, and the mixture was concentrated under reduced pressure.
残留物にクロロホルム30−を加え抽出し、水10−で
洗浄する。The residue is extracted with 30% of chloroform and washed with 10% of water.
クロロホルム層は芒硝にて乾燥後、減圧留去し、四塩化
炭素より結晶化し、■−ヒドロキシー1−(3−クロロ
−4=アリルオキシフエニル)−2−メチルスルフィ:
ニル−2−メチルチオエタンを3種の立体異性体混合物
として無色結晶で520■(収率51%)得た。The chloroform layer was dried over Glauber's salt, evaporated under reduced pressure, and crystallized from carbon tetrachloride to give ■-Hydroxy-1-(3-chloro-4=allyloxyphenyl)-2-methylsulfide:
Nyl-2-methylthioethane was obtained as a mixture of three stereoisomers in the form of colorless crystals in an amount of 520 μm (yield: 51%).
この混合物は、メタノールより分号屑結晶を行ない融点
162−163℃の無色針状晶(異性体a)および融点
103〜105℃の無色針状Σ晶(異性体b)を得た。This mixture was fractionated and crystallized from methanol to obtain colorless needle-like crystals (isomer a) with a melting point of 162-163°C and colorless needle-like Σ crystals (isomer b) with a melting point of 103-105°C.
又四塩化炭素結晶化母液は、減圧濃縮後カラムクロマト
グラフィー(シリカゲル、クロロホルム)で分離し、無
色清秋物(異性体c)250■および4種の異性体混合
物70■を得た。The carbon tetrachloride crystallization mother liquor was concentrated under reduced pressure and then separated by column chromatography (silica gel, chloroform) to obtain 250 μl of a colorless clear product (isomer c) and 70 μl of a mixture of four isomers.
全収率840■(83%)。異性体(a):
IR(KBr ) : 3200cIrL−1と104
0(1m−’ 。Overall yield 840 sq. (83%). Isomer (a): IR (KBr): 3200cIrL-1 and 104
0(1m-'.
NMR(δ6−DMSO):δ1.93(3H,−重線
)、2.77(3H,−重線)、3.78(IF5幅広
い一重線) 、、4.63 (2H,二重線、。NMR (δ6-DMSO): δ1.93 (3H, doublet), 2.77 (3H, doublet), 3.78 (IF5 wide singlet), 4.63 (2H, doublet, .
J= 4.5Hz ) 5.20−6.35 (4H
1多重線) 、 6.8−7.7 (3H%多重線)。J = 4.5Hz) 5.20-6.35 (4H
1 multiplet), 6.8-7.7 (3H% multiplet).
異性体(b):
I R(KBr ) : 3200crn−’と103
5CrfL−1゜NMR(δ6−DMSO):δ2.0
5(3H,一重・線) 、 2.80 (,3H,−重
線)、3.57(IHに重線、J=5Hz)、4.70
(2Hに重線、J −= 4.5 Hz )、 5.0
0 (I H−二重線、J=5Hz)、5.25−6.
40(3H1多重線)6.8−7.8 (3H,多重線
)。Isomer (b): IR(KBr): 3200crn-' and 103
5CrfL-1°NMR (δ6-DMSO): δ2.0
5 (3H, single line), 2.80 (,3H, - double line), 3.57 (double line on IH, J=5Hz), 4.70
(Double line on 2H, J − = 4.5 Hz), 5.0
0 (I H-double, J=5Hz), 5.25-6.
40 (3H1 multiplet) 6.8-7.8 (3H, multiplet).
異性体(C):
I R(neat ) : 3300CIfL−”と1
010cm−1。Isomer (C): IR (neat): 3300CIfL-” and 1
010 cm-1.
NMR(CDCl2):δ1.96 (3H,−重線)
。NMR (CDCl2): δ1.96 (3H, - double line)
.
2.70(3H%−重線)、3.76(IHに重線、J
=8Hz)、4.52(2H,二重線、J=4.5Hz
)、4.82(IH,二重線、J=s H2)、 5.
10−6.30 (3H多重線)。2.70 (3H%-heavy line), 3.76 (heavy line on IH, J
= 8Hz), 4.52 (2H, double line, J = 4.5Hz
), 4.82 (IH, double line, J=s H2), 5.
10-6.30 (3H multiplet).
6、7−7.5 (3H,多重線)。6, 7-7.5 (3H, multiplet).
3立体異性体の結晶性混合物の元素分析
(C13H1□03S2C1):
計算値(へ): C、48,66;H,5,34;S
、 19.98 。Elemental analysis of crystalline mixture of three stereoisomers (C13H1□03S2C1): Calculated value (to): C, 48,66; H, 5,34; S
, 19.98.
実験値%) ’、 C,48,74;H,5,33;S
、 20.15 。Experimental value %)', C, 48,74; H, 5,33; S
, 20.15.
参考例 3
■−アセトキシー1−(3−クロロ−4−アリルオキシ
フェニル)−2−メチルヌルフィニル−2−メチルチオ
エタン450■をメタノール25m1に溶解し、トリエ
チルアミン0.4−を加えた後、8時間加熱還流する。Reference Example 3 450 ml of -acetoxy 1-(3-chloro-4-allyloxyphenyl)-2-methylnurfinyl-2-methylthioethane was dissolved in 25 ml of methanol, and 0.4-triethylamine was added. Heat to reflux for 8 hours.
溶媒を減圧留去後カラムクロマトグラフィー(シリカゲ
ル、クロロホルム)により分離精製し、■−メチルヌル
フィニルー1−メチルチオ−2−(3−クロロ−4−ア
リルオキシフェニル)エチレン3407n+!(収率8
0%)を得た。After distilling off the solvent under reduced pressure, it was separated and purified by column chromatography (silica gel, chloroform) to obtain ■-methylnurfinyl-1-methylthio-2-(3-chloro-4-allyloxyphenyl)ethylene 3407n+! (yield 8
0%) was obtained.
IR(neat ) : 1060CIrL−” 。IR(neat): 1060CIrL-”.
NMR(CC14) :δ2.30(3H,−重線)。NMR (CC14): δ2.30 (3H, - double line).
2.62(3H,−重線) 、 4.62(2Hに重線
、J= 4.5Hz )、5.20−6.35 (3H
。2.62 (3H, - double line), 4.62 (2H double line, J = 4.5Hz), 5.20-6.35 (3H
.
多重線)、7.42(IH,−重線)、6.89−8.
06 (3H,多重線)。multiplet), 7.42 (IH, -multiplet), 6.89-8.
06 (3H, multiplet).
元素分析(C13H150□52C1):計算値%):
C,51,56;H,4,99;S、21.17゜実
験値(へ):C,51,62;H,4,93;S、21
.25゜参考例 4
■−メチルヌルフィニルー1−メチルチオ−2−(3−
クロロ−4−アリルオキシフェニル)エチレン2.6g
を1,2−ジメトキシエタン2〇−に溶解した後、濃塩
酸87727!!を少量づつ加え室温で25時間攪拌す
る。Elemental analysis (C13H150□52C1): Calculated value %):
C, 51,56; H, 4,99; S, 21.17° Experimental value (to): C, 51,62; H, 4,93; S, 21
.. 25° Reference Example 4 ■-Methylnurfinyl-1-methylthio-2-(3-
2.6 g of chloro-4-allyloxyphenyl)ethylene
After dissolving in 1,2-dimethoxyethane 20-, concentrated hydrochloric acid 87727! ! was added little by little and stirred at room temperature for 25 hours.
クロロホルム150rnlと水30m1を加えたのち、
水層をさらにクロロホルム50m1で抽出する。After adding 150rnl of chloroform and 30ml of water,
The aqueous layer is further extracted with 50 ml of chloroform.
有機層をあわせ無水硫酸マグネシウムで乾燥後クロロホ
ルムを留去、残留物にエーテル100−を加え、重炭酸
ナトリウム飽和水溶液で抽出する(60ydで2回)。The organic layers were combined, dried over anhydrous magnesium sulfate, and then chloroform was distilled off. Ether 100- was added to the residue, and extracted with a saturated aqueous solution of sodium bicarbonate (twice at 60 yd).
水層を塩酸で酸性にしたのちクロロホルムで抽出する(
10〇−で3回)。The aqueous layer is made acidic with hydrochloric acid and then extracted with chloroform (
100-3 times).
抽出液を無水硫酸マグネシウムで乾燥後溶媒を留去し、
シクロヘキサンから結晶化、再結晶して融点91−92
℃の無色針状晶として3−クロロ−4−アリルオキシフ
ェニル酢酸1、68 、!i+ (収率86.8%)を
得た。After drying the extract over anhydrous magnesium sulfate, the solvent was distilled off.
Crystallized from cyclohexane, recrystallized with melting point 91-92
3-chloro-4-allyloxyphenylacetic acid as colorless needles at 1,68,! i+ (yield 86.8%) was obtained.
IR(KBr ) : 1690cm−” 。IR (KBr): 1690cm-”.
NMR(CDCl2):δ3.52(2H,−重線)。NMR (CDCl2): δ3.52 (2H, - double line).
4.58(2H,二重線、J=4.5Hz)。4.58 (2H, doublet, J=4.5Hz).
5.18−6.32 (3H,多重線)、6.72−7
.52(3H1多重線) 、 11.56(IH%−重
線)。5.18-6.32 (3H, multiplet), 6.72-7
.. 52 (3H1 multiplet), 11.56 (IH% multiplet).
元素分析(C1、Hl、03C1):
計算値%): C,60,98;H,5,11実験値(
へ): C,61,05;H,5,06カラゲニン浮腫
法による本発明化合物の消炎作用く実験法〉
実施例1で得た本発明化合物を0.3%カルボキシメチ
ルセルローヌ・ナトリウム(CMC−Na)に懸濁し、
SD系雌雄性ラット1群5匹、体重110〜14o、y
)に経口投与した。Elemental analysis (C1, Hl, 03C1): Calculated value %): C, 60,98; H, 5, 11 Experimental value (
): C,61,05; H,5,06 Experimental method for anti-inflammatory action of the present compound by carrageenan edema method> The present compound obtained in Example 1 was added to 0.3% carboxymethyl cellulone sodium (CMC). - suspended in Na);
SD male and female rats, 5 rats per group, body weight 110-14o, y
) was administered orally.
投与1時間後に1%カラゲニン溶液0.1−を各ラット
の右後肢足鍍に皮下投与し、その後1時間毎に定容積を
測定し、次式:
(但し、E Cはコントロール群の浮腫強度の乎均値を
、EDは被験薬投与群の浮腫強度を示す)
により抑制率%)を算出した〇
なお、コントロール群は被験薬の代りに0.3%CMC
−Naのみを経口投与した。One hour after administration, 1% carrageenan solution 0.1- was subcutaneously administered to the right hind paw of each rat, and then a constant volume was measured every hour. ED indicates the edema intensity of the test drug administered group), and the inhibition rate (%) was calculated. In addition, the control group received 0.3% CMC instead of the test drug.
-Na alone was orally administered.
また対照薬としてフェニルブクゾン(PB)を用いた。Furthermore, phenylbucusone (PB) was used as a control drug.
〈結果〉
本発明化合物および対照薬の12.5,25.50およ
び100ml1/KPの各投与量における抑制率(被験
薬の投与後3時間での値)を表1に示す。<Results> Table 1 shows the inhibition rates (values 3 hours after administration of the test drug) of the compound of the present invention and the control drug at each dose of 12.5, 25.50, and 100 ml/KP.
、 表 1
抑制率(%
投与量(772≠p) 12.5 25 50 1
00投与群
対照薬(PB) 11,7 16.7 32.9 3
7.5) 本発明化合物 21.0 29.2 39.
4 49.5(実施例1)
表1に示す如く、本発明化合物はPBに優る抗浮腫活性
を示した。, Table 1 Inhibition rate (% Dose (772≠p) 12.5 25 50 1
00 administration group control drug (PB) 11.7 16.7 32.9 3
7.5) Compound of the present invention 21.0 29.2 39.
4 49.5 (Example 1) As shown in Table 1, the compound of the present invention exhibited anti-edema activity superior to PB.
Claims (1)
基、アセチル基またはベンゾイル基である特許請求の範
囲第1項に記載の化合物。 3 一般式 (式中、R1及びR2はアルキル基である。 )で示されるα−ヒドロキシアルデヒドメルカプタール
S−オキシドをアルキル化、アシル化またはアロイル化
することを特徴とする、一般式 (式中、R1及びR2はアルキル基であり、R3はアル
キル基、アシル基またはアロイル基である。 )で示されるβ−オキシヌルホキシト類の製造法。[Scope of Claims] 1. A β-oxynulphoxide derivative represented by the general formula (wherein R1 and R2 are an alkyl group, and R3 is an alkyl group, an acyl group, or an aroyl group). 2. The compound according to claim 1, wherein R'' and R2 are methyl groups, and R'' is a methyl group, an acetyl group, or a benzoyl group. 3. A compound of the general formula (wherein R1 and R2 are alkyl groups) characterized by alkylating, acylating or aroylating α-hydroxyaldehyde mercaptal S-oxide represented by the general formula (wherein R1 and R2 are alkyl groups). (wherein, R1 and R2 are alkyl groups, and R3 is an alkyl group, an acyl group, or an aroyl group).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6062776A JPS5822032B2 (en) | 1976-05-27 | 1976-05-27 | β-oxysulfoxide derivative and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6062776A JPS5822032B2 (en) | 1976-05-27 | 1976-05-27 | β-oxysulfoxide derivative and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52144647A JPS52144647A (en) | 1977-12-02 |
| JPS5822032B2 true JPS5822032B2 (en) | 1983-05-06 |
Family
ID=13147717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6062776A Expired JPS5822032B2 (en) | 1976-05-27 | 1976-05-27 | β-oxysulfoxide derivative and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5822032B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59145219U (en) * | 1983-03-16 | 1984-09-28 | 株式会社大井製作所 | Stops for electrical wiring inside automobile doors |
-
1976
- 1976-05-27 JP JP6062776A patent/JPS5822032B2/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59145219U (en) * | 1983-03-16 | 1984-09-28 | 株式会社大井製作所 | Stops for electrical wiring inside automobile doors |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52144647A (en) | 1977-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2655692B2 (en) | Sulfonamidothienylcarboxylic acid compound | |
| CA2412368A1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
| US3853952A (en) | 2-ethynylcyclopropane compounds and process for the preparation thereof | |
| EP0343050B1 (en) | 6-phenyl-3-piperazinylalkyl 1h,3h-pyrimidinedione-2,4 derivatives, their preparation and their use in therapy | |
| EP0540400A1 (en) | Quinoline derivatives, useful as angiotensin II antagonists | |
| JP3030780B2 (en) | Optically active ketene dithioacetal derivative and method for producing the same | |
| JPH04334331A (en) | Carbacyclin homologue | |
| US3860636A (en) | Substituted indenyl phosphonic acids having anti-inflammatory activity | |
| HU218494B (en) | Process for producing pure enantiomere cycloalkano indole-,-azacykloalkano-indole- and pyrymido[1,2-a]indole-carbonic acids and their activated derivatives, as well as intermediates thereof | |
| EP0068386B1 (en) | Substituted imidazo(1,5-a)pyridines, process for their preparation and pharmaceutical preparations containing these compounds | |
| JPS5822032B2 (en) | β-oxysulfoxide derivative and method for producing the same | |
| DE2337068A1 (en) | 1-BENZYLINDENYL ACIDS | |
| DE2402705A1 (en) | TETRAHYDROFLUORENIC ACIDS | |
| JPS63145286A (en) | Bicyclic imidazole derivative | |
| EP0365194B1 (en) | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides | |
| FI67535C (en) | FORM OF TRICYCLIC AMINER FRAMSTAELLNING AV NYA BIOLOGISKT ACTIVE | |
| JPS588391B2 (en) | α-Hydroxyaldehyde mercaptal S-oxides and their production method | |
| US3133963A (en) | Benzamides | |
| JPS61100555A (en) | Benzophenone oxime derivative | |
| JPS5822031B2 (en) | β-Ketosulfoxides and their production method | |
| FR2649394A1 (en) | AZULENE DERIVATIVES, ANTAGONISTS OF ENDOPEROXIDE RECEPTORS OF THROMBOXANE A2 AND PROSTAGLANDINS, AND PROCESS FOR THEIR PREPARATION | |
| JPH06247919A (en) | Benzoic acid derivative and its use | |
| US2889325A (en) | Derivatives of 1, 3 (2h)-dioxo-1-pyrazolo [a]-benzo [c] cinnoline | |
| JPS58126835A (en) | Inter-m-phenylene-prostacycline analogue and manufacture | |
| JPS5811437B2 (en) | 1-Sulfinyl-1-thio-2-(3-chloro-4-allyloxyphenyl)ethylene |